[6] results for :

Oncology: 2015 ASH Review - Lymphoma Presented by Nancy L. Bartlett, MD
Live   |   1 Credit(s)

New Course
LEARNING OBJECTIVES Following the presentation, each participant should be able to: 1.Improve patient management through the introduction of new or updated knowledge, techniques, equipment, or drugs. 2.Identify appropriate procedures and treatments and attempt to modify behaviors, change practice patterns or raise awar

Release Date: 1/23/2017   |   End Date: 4/18/2018
Oncology: 2015 ASH Review What is Refractory AML Presented by Eli Estey, MD
Live

New Course
1.Improve patient management through the introduction of new or updated knowledge, techniques, equipment, or drugs. 2.Identify appropriate procedures and treatments and attempt to modify behaviors, change practice patterns or raise awareness of potential problems identified through M&M and/or continuous quality improvem

Release Date: 1/23/2017   |   End Date: 4/18/2018
Oncology: 2015 ASH Review Individualized Care of MPNs Presented by Ruben Mesa, MD, FACP
Live   |   1 Credit(s)

New Course
LEARNING OBJECTIVES Following the presentation, each participant should be able to: 1.Improve patient management through the introduction of new or updated knowledge, techniques, equipment, or drugs. 2.Identify appropriate procedures and treatments and attempt to modify behaviors, change practice patterns or raise awar

Release Date: 1/23/2017   |   End Date: 4/18/2018
Oncology: Neuroendocrine Tumors - Presented by Eric Liu, MD
Live

New Course
LEARNING OBJECTIVES Following the presentation, each participant should be able to: Describe the current and novel methods of diagnosing neuroendocrine tumors (NETS). Describe the current and novel methods of treating NETS. Explain current epidemiological and demographic data on NETS.

Release Date: 1/23/2017   |   End Date: 1/01/2018
Oncology: 2015 ASH Review Multiple Myeloma & Amyloidosis Presented by Jeffrey A. Zonder, MD
Live

New Course
2015 ASH Review Multiple Myeloma & Amyloidosis Presented by Jeffrey A. Zonder, MD

Release Date: 1/23/2017   |   End Date: 4/18/2018
Oncology: Phase 1 Clinical Trials in the Era of Targeted Cancer Therapy - Presented by Gerald Falchook, MD, MS
Enduring   |   1 Credit(s)

LEARNING OBJECTIVES Following the presentation, each participant should be able to: Discuss the goals of phase 1 clinical trials Differentiate phase 1 from phase 2 and 3 trials Describe the design of phase 1 trials Discuss safety and potential efficacy for patients who enroll on phase 1 trials.

Release Date: 11/05/2014   |   End Date: 11/05/2017